PetMed Express, Inc. logo

PetMed Express, Inc.

PETS

NASDAQConsumer CyclicalSpecialty Retail

Previous close

$1.76

$0.00 · 0.00%

Aug 21, 4:00 PM ET

PETS company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

47

Fair Value

Momentum

26

Weakening

Sentiment

53

Mixed

Risk resilience

33

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

PetMed Express, Inc., through its various subsidiaries, operates as a prominent pet pharmacy across the United States. The company provides a comprehensive range of both prescribed and over-the-counter animal medications, health-related items, and other essential supplies for canines, felines, and equines. Their non-prescription offerings include products for flea and tick prevention, joint and bone care, vitamins, treats, nutritional supplements, hygiene essentials, and general pet supplies. For prescription needs, they supply heartworm and flea/tick preventatives, alongside medications for conditions such as arthritis, dermatitis, thyroid imbalances, diabetes, pain relief, and cardiovascular issues, often providing generic alternatives. Beyond pharmaceuticals, the company also retails pet food, bedding, crates, stairs, and various other accessories. PetMed Express engages with its clientele through multiple distribution channels: its official website, a dedicated mobile application, a telephone contact center, direct mail campaigns (like brochures and postcards), and television advertisements, frequently promoting its 1-800-PetMeds and PetMeds brands. The company was established in 1996 and is headquartered in Delray Beach, Florida.

Industry
Specialty Retail
Sector
Consumer Cyclical
Headquarters
US
CEO
Leslie C. G. Campbell
Listed since
Apr 26, 1999
Employees
189

Market position

Day range

Current $1.76

52-week range

Current $1.76

Open
$1.765
Previous close
$1.76
Volume
50.35K
0.08× average
Average volume
643.66K
Average daily volume
Market cap
37.61M USD
Beta
0.79
Market reference 1
50-day average
$1.9112
-7.91% below average
200-day average
$2.397
-26.57% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
26.82M USD
P/E (TTM)
-1.28×
P/B (TTM)
1.66×
P/S (TTM)
0.22×
EV / EBITDA
-1.22×
Earnings yield
-120.09%
Free cash flow yield
-69.20%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
23.71%
Operating margin
-18.22%
Net margin
-17.34%
Return on equity
-197.95%
Return on assets
-70.56%
Return on invested capital
-105.82%

Financial health

Debt / equity
0.02×
Current ratio
0.84×
Altman Z-score
1.42
Piotroski F-score
3 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends37%12%-13%-38%Gross margin, FY2022: 27.55%Gross margin, FY2023: 27.68%Gross margin, FY2024: 28.35%Gross margin, FY2025: 30.46%Gross margin, FY2026: 22.81%Operating margin, FY2022: 9.40%Operating margin, FY2023: 2.55%Operating margin, FY2024: -2.54%Operating margin, FY2025: -0.67%Operating margin, FY2026: -17.55%Net margin, FY2022: 7.72%Net margin, FY2023: 2.00%Net margin, FY2024: -2.72%Net margin, FY2025: -2.76%Net margin, FY2026: -32.00%FY2022FY2023FY2024FY2025FY2026
Gross margin FY2022 27.55%. Gross margin FY2023 27.68%. Gross margin FY2024 28.35%. Gross margin FY2025 30.46%. Gross margin FY2026 22.81%. Operating margin FY2022 9.40%. Operating margin FY2023 2.55%. Operating margin FY2024 -2.54%. Operating margin FY2025 -0.67%. Operating margin FY2026 -17.55%. Net margin FY2022 7.72%. Net margin FY2023 2.00%. Net margin FY2024 -2.72%. Net margin FY2025 -2.76%. Net margin FY2026 -32.00%.

Income trends

Revenue

179.02M USD-21.13%

Operating income

−31.42M USD-1953.27%

Net income

−57.29M USD-813.51%
Income trends across reported periods307.23M USD174.68M USD42.13M USD−90.42M USDRevenue, FY2022: 273.42M USDRevenue, FY2023: 256.58M USDRevenue, FY2024: 274.1M USDRevenue, FY2025: 226.97M USDRevenue, FY2026: 179.02M USDOperating income, FY2022: 25.71M USDOperating income, FY2023: 6.55M USDOperating income, FY2024: −6.96M USDOperating income, FY2025: −1.53M USDOperating income, FY2026: −31.42M USDNet income, FY2022: 21.1M USDNet income, FY2023: 5.14M USDNet income, FY2024: −7.46M USDNet income, FY2025: −6.27M USDNet income, FY2026: −57.29M USDFY2022FY2023FY2024FY2025FY2026
Revenue FY2022 273.42M USD. Revenue FY2023 256.58M USD. Revenue FY2024 274.1M USD. Revenue FY2025 226.97M USD. Revenue FY2026 179.02M USD. Operating income FY2022 25.71M USD. Operating income FY2023 6.55M USD. Operating income FY2024 −6.96M USD. Operating income FY2025 −1.53M USD. Operating income FY2026 −31.42M USD. Net income FY2022 21.1M USD. Net income FY2023 5.14M USD. Net income FY2024 −7.46M USD. Net income FY2025 −6.27M USD. Net income FY2026 −57.29M USD.
Metric (USD)FY2026FY2025FY2024FY2023FY2022
Revenue179.02M USD226.97M USD274.1M USD256.58M USD273.42M USD
Cost of goods sold138.19M USD157.84M USD196.38M USD185.84M USD198.08M USD
Gross profit40.83M USD69.14M USD77.71M USD71.01M USD75.34M USD
Selling, general, and administrative72.24M USD62.43M USD79.75M USD68.9M USD49.63M USD
Operating expenses72.24M USD70.67M USD84.67M USD64.68M USD49.63M USD
Interest income511K USD511K USD450K USD335K USD
Depreciation and amortization9.39M USD7.04M USD7.06M USD3.55M USD2.74M USD
Operating income−31.42M USD−1.53M USD−6.96M USD6.55M USD25.71M USD
Net income−57.29M USD−6.27M USD−7.46M USD5.14M USD21.1M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
20%
2 beats, 8 misses, 0 met estimates
Average EPS surprise
-374.27%
10 comparable reports
Latest EPS result
-0.28
Estimate 0.12 · Miss by 333.33%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.17-0.07-0.31-0.55Q3 '25MissQ3 '25MissQ4 '25MissQ1 '26MissQ2 '26MissQ3 '26MissQ4 '26EstimateQ4 '26Estimate
Q3 2025, reported Aug 26, 2025: actual -0.49, estimate -0.06, surprise -716.67%, Miss. Q3 2025, reported Sep 30, 2025: actual -0.07, estimate -0.06, surprise -16.67%, Miss. Q4 2025, reported Dec 19, 2025: actual -0.34, estimate -0.02, surprise -1600.00%, Miss. Q1 2026, reported Feb 5, 2026: actual -0.5, estimate -0.06, surprise -733.33%, Miss. Q2 2026, reported Jun 2, 2026: actual -0.19, estimate -0.18, surprise -5.56%, Miss. Q3 2026, reported Aug 13, 2026: actual -0.28, estimate 0.12, surprise -333.33%, Miss. Q4 2026, reported Oct 13, 2026: actual —, estimate -0.06, surprise —, Comparison unavailable. Q4 2026, reported Dec 18, 2026: actual —, estimate -0.06, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates73.84M61.83M49.83M37.82MQ3 '25MissQ3 '25MissQ4 '25MissQ1 '26MissQ2 '26MissQ3 '26MissQ4 '26EstimateQ4 '26Estimate
Q3 2025, reported Aug 26, 2025: actual 51.1M USD, estimate 69.31M USD, surprise -26.27%, Miss. Q3 2025, reported Sep 30, 2025: actual 51.18M USD, estimate 69.31M USD, surprise -26.16%, Miss. Q4 2025, reported Dec 19, 2025: actual 44.36M USD, estimate 69.31M USD, surprise -35.99%, Miss. Q1 2026, reported Feb 5, 2026: actual 40.66M USD, estimate 54.04M USD, surprise -24.77%, Miss. Q2 2026, reported Jun 2, 2026: actual 42.82M USD, estimate 52M USD, surprise -17.66%, Miss. Q3 2026, reported Aug 13, 2026: actual 41.02M USD, estimate 71M USD, surprise -42.23%, Miss. Q4 2026, reported Oct 13, 2026: actual —, estimate 62M USD, surprise —, Comparison unavailable. Q4 2026, reported Dec 18, 2026: actual —, estimate 55M USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$11.00

525.00% upside
Past 12 months12-month forecastHigh $19.00Average $11.00Low $7.00

Rating distribution

10 ratings
Strong buy00%
Buy220%
Hold660%
Sell220%
Strong sell00%

Recent analyst actions

2 institutions

PETS news

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

$1.20

2022 complete year+15.4% since 2018

Corporate action history

Dividend

Ex-dividend Aug 11, 2023

$0.30

Quarterly

Record Aug 14, 2023 · Payment Aug 18, 2023

Dividend

Ex-dividend Jun 5, 2023

$0.30

Quarterly

Record Jun 6, 2023 · Payment Jun 12, 2023

Dividend

Ex-dividend Feb 16, 2023

$0.30

Quarterly

Record Feb 20, 2023 · Payment Feb 27, 2023

Dividend

Ex-dividend Nov 17, 2022

$0.30

Quarterly

Record Nov 18, 2022 · Payment Nov 30, 2022

Dividend

Ex-dividend Aug 11, 2022

$0.30

Quarterly

Record Aug 12, 2022 · Payment Aug 19, 2022

Dividend

Ex-dividend May 19, 2022

$0.30

Quarterly

Record May 20, 2022 · Payment May 27, 2022

PETS peers

ETFs holding PETS

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research PETS

research.disclaimer